Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
08/2012
08/01/2012CN102614105A Brain targeted amphotericin B (AmB) polymer micelle administration system
08/01/2012CN102198132B Solid preparation of pharmaceutical composition of ketoprofen and omeprazole
08/01/2012CN102144969B Method for preparing etoposide nanometer suspension freeze-drying preparation
08/01/2012CN102133186B Racecadotril liposome solid preparation
08/01/2012CN102120855B pH-responsive three-dimensional ordered macroporous controlled-release material
08/01/2012CN102091039B Cefteram pivoxil liposome solid preparation
08/01/2012CN102070791B Polyvinyl alcohol crosslinked thiolated hyaluronic acid/polyvinyl alcohol film and preparation method and application thereof
08/01/2012CN102008443B 4-amino-2-trifluoromethyl-phenylretinate solid dispersion and preparation method thereof
08/01/2012CN101947210B Levoamlodipine besylate liposome tablet
08/01/2012CN101797230B Liposome solid preparation of losartan potassium hydrochlorothiazide pharmaceutical composition
08/01/2012CN101579525B Disintegrating agent as well as manufacturing method and application method thereof
08/01/2012CN101198319B Granular preparation containing biguanide compound
08/01/2012CN101184511B Preparation comprising microparticles of complex composed of nucleic acid molecule and collagen
07/2012
07/31/2012US8232388 Granulated maltitol for direct compression and method of preparation thereof
07/31/2012US8232383 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
07/31/2012US8232371 Modified human interferon polypeptides and their uses
07/31/2012US8232348 Masterbatch and polymer composition
07/31/2012US8232322 High molecular weight polymers, devices and method for making and using same
07/31/2012US8232304 Antifungal formulations
07/31/2012US8232276 Anhydrous topical skin preparations
07/31/2012US8232264 Free of medium chain glycerides; topical delivery to skin; vehicle comprising at least two penetration enhancers such as propylene glycol, diisopropyl adipate, dimethyl isosorbide, 1,2,6-hexanetriol, and benzyl alcohol, as well as solvents and emulsifiers
07/31/2012US8232259 Multiple CpG oligodeoxynucleotide and their use to induce an immune response
07/31/2012US8232251 Compounds for delivery of therapeutic and imaging moieties to nerve cells
07/31/2012US8231910 Combining EDTA-sodium-metal complex(es) and the sodium selenite solution to from trace element soultuton to provide the solution to the animals
07/31/2012US8231905 Gastric retained gabapentin dosage form
07/31/2012US8231903 Controlled release system
07/31/2012US8231897 Hydrostatic delivery system for controlled delivery of agent
07/31/2012US8231889 Method of forming medical devices having pyrogen removed for in vivo application
07/31/2012US8231875 Neutralising antibody molecules having specificity for human IL-17
07/31/2012CA2703688C Use of bile acid or bile salt fatty acid conjugates
07/31/2012CA2524710C Controlled release of active agents utilizing repeat sequence protein polymers
07/31/2012CA2481227C Adherent n,o-carboxymethylchitosan drug delivery devices for moist tissue and methods of their use
07/31/2012CA2358958C Soy depigmenting and skin care compositions
07/26/2012WO2012100050A1 A composition for the attachment of implants to collagen or other components of biological tissue
07/26/2012WO2012099805A2 Nanoparticle based immunological stimulation
07/26/2012WO2012099479A1 Injectable compositions for mastitis comprising an nsaid and an antibiotic in a non-aqueous solvent
07/26/2012WO2012099293A1 Radiation cross-linked collagen gel, and preparation method and usage method thereof
07/26/2012WO2012099142A1 Bromfenac aqueous liquid composition having preservative efficiency
07/26/2012WO2012099082A1 Branched-chain amino acid-containing jelly
07/26/2012WO2012098937A1 Method for producing liposome
07/26/2012WO2012098562A2 Liquid oral compositions of lanthanum salts
07/26/2012WO2012098557A1 Pegylated gemcitabine derivative and process for preparing the same
07/26/2012WO2012098499A1 Solid molecular dispersion
07/26/2012WO2012098342A1 (r)-1,2-propanediol for use as a solvent in therapeutic cooling agent compositions
07/26/2012WO2012098222A1 Bisphosphonate-polyaspartamide conjugates as polymeric carriers for drug targeting to bones
07/26/2012WO2012097876A1 Corona-like (guanidyl)-oligosaccharidic derivatives as cell-penetrating enhancers for intracellular delivery of colloidal therapeutic systems
07/26/2012WO2012097447A1 Carboxymethyl starch and chitosan polyelectrolyte complexes
07/26/2012WO2012074244A3 Injectable liquid composition or injectable dried powder containing revaprazan or its salt
07/26/2012WO2012074243A3 Injectable liquid composition containing revaprazan or its salt
07/26/2012WO2012066581A9 Novel conjugates for targeted drug delivery
07/26/2012WO2012063257A3 Sustained release compositions
07/26/2012WO2012059936A4 Pharmaceutical compositions for colloidal drug delivery
07/26/2012WO2012046994A9 Nitric oxide delivery system using thermosensitive synthetic polymers
07/26/2012WO2012039768A3 Itraconazole formulations
07/26/2012WO2012013515A3 Skin patch having optimized active substance release
07/26/2012WO2011157428A3 In-situ lecithin microemulsion gel formulation
07/26/2012WO2011154711A8 Peptide-carrying nanoparticles
07/26/2012WO2011107283A3 Formulations of taurolidine and method for the production thereof
07/26/2012WO2011080595A3 Polysaccharide immunogens conjugated to e. coli carrier proteins
07/26/2012US20120190755 Reactive 1-component roadway marking
07/26/2012US20120190658 Method And Composition For The Treatment Of Adverse Skin Conditions
07/26/2012US20120189750 Taste Modifiers Comprising a Chlorogenic Acid
07/26/2012US20120189713 Monomers and phase-separated biocompatible polymer compositions prepared therefrom for medical uses
07/26/2012US20120189704 Novel injectable chitosan mixtures forming hydrogels
07/26/2012US20120189696 Coating film, and granules and tablets each utilizing same
07/26/2012US20120189694 Co-precipitate comprising a phosphodiesterase-5 inhibitor (pde-5-inhibitor) and a pharmaceutically compatible carrier, production and use thereof
07/26/2012US20120189691 Drug carrier and drug carrier kit for inhibiting fibrosis
07/26/2012US20120189689 Acoustically sensitive drug delivery particles comprising non-lamellar forming phosphatidylcholine
07/26/2012US20120189669 Solid Forms for Tissue Repair
07/26/2012US20120189666 Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent
07/26/2012US20120189602 Treatment and prevention of pulmonary conditions
07/26/2012US20120189601 Assisted enzyme replacement therapy
07/26/2012US20120189584 Genipin cross-linked fibrin gels
07/26/2012US20120189554 Multi-functional drug carriers
07/26/2012CA2824827A1 (r)-1,2-propanediol for use as a solvent in therapeutic cooling agent compositions
07/26/2012CA2824433A1 Aqueous liquid bromfenac composition having preservative efficacy
07/26/2012CA2823686A1 Radiation cross-linked collagen gel, and preparation method and usage method thereof
07/26/2012CA2823622A1 Solid molecular dispersion of fesoterodine
07/25/2012EP2479184A2 Beta immunogenic peptide carrier conjugates and methods of producing the same
07/25/2012EP2478919A1 Osmotic pump controlled release tablet and preparation method thereof
07/25/2012EP2478914A1 Modified erythropoietin to which water-soluble long-chain molecule is added
07/25/2012EP2478912A1 Auristatin conjugates with anti-HER2 or anti-CD22 antibodies and their use in therapy
07/25/2012EP2478906A1 Latanoprost-containing aqueous eye drops and method for inhibiting adsorption of latanoprost to resin
07/25/2012EP2478904A1 A pharmaceutical composition for peroral administration of diindolylmethane
07/25/2012EP2478897A2 Pad for herbal medicine in which release of medicinal ingredient can be controlled, and manufacturing method thereof
07/25/2012EP2478361A2 Protein kinase conjugates and inhibitors
07/25/2012EP2478110A1 Class i anti-cea antibodies and uses thereof
07/25/2012EP2478019A1 Pellets coated with coatings containing active substances
07/25/2012EP2477644A1 Stable non-aqueous liquid pharmaceutical compositions comprising an insulin
07/25/2012EP2477643A1 Long-acting y2 receptor agonists
07/25/2012EP2477625A2 Pharmaceutical compositions and formulations including inhibitors of the pleckstrin homology domain and methods for using same
07/25/2012EP2477606A1 Rapidly soluble solid pharmaceutical preparations containing amphiphilic copolymers based on polyethers in combination with hydrophilic polymers
07/25/2012EP2477605A1 Solid pharmaceutical preparations comprising amphiphilic copolymers on the basis of polyethers in combination with surfactants
07/25/2012EP2477603A2 Stable co-formulation of hyaluronidase and immunoglobulin, and methods of use thereof
07/25/2012EP2274016B1 Pegylated igf-i variants for use in the treatment of neuromuscular disorders
07/25/2012EP2170400B1 Pharmaceutical liquid composition of botulinum toxin with improved stability
07/25/2012EP2131867B1 Modified hydroxypolymer conjugates with killing effect on tumor cells
07/25/2012EP1858541B1 Use of bmp antagonists to regulate hepcidin-mediated iron metabolism and treat iron deficiency
07/25/2012EP1848419B1 Injectable preparations of diclofenac and its pharmaceutically acceptable salts
07/25/2012EP1811995B1 A transmucosal veterinary composition comprising detomidine
1 ... 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 ... 1712